Jayant Acharya, MD
Neurology · Springfield, ILNPI 1891710695
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (44.2%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Medtronic at 46.9% of the total. Reporting peaked in 2019 at $2,129 and has fallen 56.2% since, to $932 in 2025.
Across 53 payments — averaging $82.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Neuropace, Inc.$870
- Voxneuro USA Inc.$500
- Greenwich Biosciences, Inc.$423
- SK Life Science, Inc.$259
- AbbVie$112
- plus $157 from 3 others
Across 38 payments — averaging $924.97 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Neuropace, Inc.$35K
What the payments were for
- Consulting fees$50011%
- Travel & lodging$1,90444%
- Food & beverage$1,93244%
- Education$361%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 21 | $2,052 |
| Neuropace, Inc. | 3 | $870 |
| Voxneuro USA Inc. | 1 | $500 |
| Greenwich Biosciences, Inc. | 4 | $423 |
| SK Life Science, Inc. | 20 | $259 |
| AbbVie | 1 | $112 |
| Jazz Pharmaceuticals Inc. | 1 | $82 |
| Neurelis, Inc. | 1 | $58 |
| Catalyst Pharmaceuticals, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RNS System$870
- ACTIVA$839
- PERCEPT PC BRAINSENSE$414
- Epidiolex$269
- UBRELVY$112
How this compares
$4,372 in reported general payments places this provider in the 70th percentile of 790 neurology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Depakote ErDivalproex Sodium | 13 | $6,906 |
| Lacosamide | 15 | $5,080 |
| Divalproex Sodium | 35 | $3,622 |
| Levetiracetam | 37 | $1,952 |
| Carbamazepine | 23 | $1,484 |
| Acetazolamide | 13 | $340 |
Paid to pharmacies, not to this prescriber.
Other neurology in Springfield
- Rodger ElbleSpringfield$47K
- Augusto MiravalleChicago$1.4M
- Lori GuytonHerrin$1.1M
- Daniel WynnNorthbrook$812K
- Arthur ItkinPalos Heights$808K
- Andrew GordonLake Barrington$765K
- Martha McGrawWinfield$625K
- Reuben ValenzuelaPeoria$590K
- Adil JavedChicago$584K
- Tyler KaplanMaywood$549K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.